首页> 外文期刊>Artificial Organs >Teicoplanin Pharmacokinetics During Albumin Dialysis
【24h】

Teicoplanin Pharmacokinetics During Albumin Dialysis

机译:白蛋白透析期间替考拉宁的药代动力学

获取原文
获取原文并翻译 | 示例
           

摘要

Teicoplanin (TP) pharmacokinetics was assessed in a critically ill patient during albumin dialysis (AD), which was performed with the molecular adsorbent recirculating system. After a 1200-mg loading dose (24?mg/kg), doses of 1200 and 1000?mg (20?mg/kg) on day 2 and 3, respectively, were administered during two cycles of AD. The mean TP peak and trough concentrations amounted to 99.3 and 21.4?μg/mL, respectively, during AD. A mean half-life of 5.5?h, an apparent volume of distribution of 0.302?L/kg, and a mean total TP clearance of 39?mL/h/kg were calculated. Ninety minutes after the start of AD, the extracorporeal clearance was 3560?mL/h. Within 8?h of AD therapy, the serum concentrations decreased by about 75%. Despite a considerable elimination of TP by AD, therapeutic serum levels could be maintained during the entire treatment by administration of high doses and close monitoring of TP serum concentrations.
机译:在白蛋白透析(AD)期间,对重症患者的Teicoplanin(TP)药代动力学进行了评估,这是通过分子吸附剂再循环系统进行的。 1200 mg负荷剂量(24?mg / kg)后,在两个AD周期中分别在第2天和第3天给予1200和1000?mg(20?mg / kg)剂量。在AD期间,平均TP峰和谷浓度分别为99.3和21.4μg/ mL。计算的平均半衰期为5.5?h,表观分布体积为0.302?L / kg,平均总TP清除率为39?mL / h / kg。 AD开始后90分钟,体外清除率为3560?mL / h。在AD治疗的8小时内,血清浓度降低了约75%。尽管AD显着消除了TP,但在整个治疗过程中,可通过给予高剂量并密切监测TP血清浓度来维持治疗性血清水平。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号